About Complejo Hospitalario de Jaen
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Spanish Breast Cancer Research Group
21
Pfizer
9
Hoffmann-La Roche
6
PETHEMA Foundation
6
Fundación GECP
5
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
4
Spanish Lung Cancer Group
4
Fundación Pública Andaluza Progreso y Salud
3
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
3
Janssen Research & Development, LLC
3
MedSIR
3
Clinical Trials at Complejo Hospitalario de Jaen
During the past decade, Complejo Hospitalario de Jaen conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 35 clinical trials were completed, i.e. on
average, 54.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 14 clinical trials were completed. i.e. 70%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients
2003-03-01
2015-01-01
Completed
46
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
2003-09-19
2013-10-01
Completed
1,925
Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
2004-01-01
2010-02-01
Completed
73
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
1999-11-01
2007-12-01
Completed
1,289
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
2004-02-01
2019-04-04
Completed
1,384
Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients
2006-01-01
2017-02-17
Completed
876
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
2006-02-15
2009-07-14
Completed
49
Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina)
2006-09-01
2009-05-01
Completed
76
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Complejo Hospitalario de Jaen" #1 sponsor was "Spanish Breast Cancer Research Group" with 21 trials, followed by "Pfizer" with 9 trials
sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "PETHEMA Foundation" with 6 trials sponsored and "Fundación GECP"
with 6 trials sponsored. Other sponsors include 62 different institutions and
companies that sponsored additional 51 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario de Jaen"
#1 collaborator was "Hoffmann-La Roche" with 7 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator, "Pfizer" with 4 trials as a collaborator and "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include 61 different institutions and companies that were
collaborators in the rest 63 trials.
Clinical Trials Conditions at Complejo Hospitalario de Jaen
According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario de Jaen" are
"Breast Cancer" (22 trials), "Breast Neoplasms" (6 trials), "Metastatic Breast Cancer" (5 trials), "Non-Small Cell Lung Cancer" (4 trials) and "Non Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Complejo Hospitalario de Jaen" in a lesser frequency.
Clinical Trials Intervention Types at Complejo Hospitalario de Jaen
Most popular intervention types in "Complejo Hospitalario de Jaen" are "Drug" (83 trials), "Other" (8 trials), "Biological" (6 trials), "Device" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (11 trials), "Carboplatin" (10 trials), "Docetaxel" (9 trials), "Placebo" (9 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.
Clinical Trials Genders at Complejo Hospitalario de Jaen
The vast majority of trials in "Complejo Hospitalario de Jaen" are
79 trials for "All" genders, 32 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Complejo Hospitalario de Jaen
Currently, there are NaN active trials in "Complejo Hospitalario de Jaen".
1 are not yet recruiting,
17 are recruiting,
14 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 68 completed trials in Complejo Hospitalario de Jaen,
undefined suspended trials,
and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Complejo Hospitalario de Jaen, 4 "Phase 1"
clinical trials were conducted, 36 "Phase 2" clinical
trials and 35 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 9 trials, and there were
also 2 trials that are defined as “Not Applicable".